# Palvella Therapeutics, Inc.: Form 8-K, filed Feb 24, 2026

- Company: [Palvella Therapeutics, Inc.](/companies/pvla.md) (CIK 1583648)
- Form: 8-K
- Filed: 2026-02-24
- Accepted by EDGAR: Feb 24, 2026, 07:55 ET
- Period: 2026-02-24
- Accession: 0001193125-26-065308
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1583648/000119312526065308/pvla-20260224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1583648/000119312526065308/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1583648/000119312526065308/pvla-20260224.htm

Filed Feb 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-065308. Last ingested by Listed: Nov 11, 2026, 01:36 ET. No prices; not investment advice.